Cargando…
Treatment decisions in VRE bacteraemia: a survey of infectious diseases pharmacists
BACKGROUND: VRE infections increased in 2020. High-dose daptomycin (≥10 mg/kg) has shown mortality benefit over other regimens, though daptomycin resistance is increasing. Limited data exist on the practice patterns of ID pharmacists for VRE bloodstream infections (VRE BSIs). OBJECTIVES: To describe...
Autores principales: | White, Bryan P, Barber, Katie E, Chastain, Daniel B |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10202426/ https://www.ncbi.nlm.nih.gov/pubmed/37223393 http://dx.doi.org/10.1093/jacamr/dlad063 |
Ejemplares similares
-
Duration of exposure to multiple antibiotics is associated with increased risk of VRE bacteraemia: a nested case-control study
por: Gouliouris, Theodore, et al.
Publicado: (2018) -
Impact of infectious diseases consultation on the outcome of patients
with bacteraemia
por: Jiménez-Aguilar, Patricia, et al.
Publicado: (2019) -
VRE in cirrhotic patients
por: Barger, Melissa, et al.
Publicado: (2019) -
Impact of infectious diseases consultation on the management of Staphylococcus aureus bacteraemia in children
por: Saunderson, Rebecca B, et al.
Publicado: (2014) -
VRE and VSE Bacteremia Outcomes in the Era of Effective VRE Therapy: A
Systematic Review and Meta-analysis
por: Prematunge, Chatura, et al.
Publicado: (2015)